GLP-2 Is Locally Produced From Human Islets and Balances Inflammation Through an Inter-Islet-Immune Cell Crosstalk

Glucagon-like peptide-1 (GLP-1) shows robust protective effects on β-cell survival and function and GLP-1 based therapies are successfully applied for type-2 diabetes (T2D) and obesity. Another cleavage product of pro-glucagon, Glucagon-like peptide-2 (GLP-2; both GLP-1 and GLP-2 are inactivated by...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Wei, Rebello, Osmond D., Henne, Antonia, Nikolka, Fabian, Klein, Thomas, Maedler, Kathrin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8287580/
https://www.ncbi.nlm.nih.gov/pubmed/34290670
http://dx.doi.org/10.3389/fendo.2021.697120

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8287580/
https://www.ncbi.nlm.nih.gov/pubmed/34290670
http://dx.doi.org/10.3389/fendo.2021.697120

Ejemplares similares